邱 宗傑

Medicine & Life Sciences

1. Taiwan 100%
2. Hematopoietic Stem Cell Transplantation 58%
3. Non-Hodgkin's Lymphoma 39%
4. Bone Marrow Transplantation 38%
5. Survival 33%
6. Drug Therapy 31%
7. Neoplasms 29%
8. Graft vs Host Disease 29%
9. Leucovorin 28%
10. Lymphoma, Large B-Cell, Diffuse 27%
11. Colorectal Neoplasms 26%
12. Rituximab 26%
13. Transplants 24%
14. Fluorouracil 23%
15. Leukemia 23%
16. Vitamin K 3 23%
17. Bone Marrow 23%
18. Lymphoma 22%
19. Homologous Transplantation 22%
20. Multiple Myeloma 21%
21. Incidence 21%
22. Leukemia, Myelogenous, Chronic, BCR-ABL Positive 20%
23. Hepatitis B virus 19%
24. Therapeutics 19%
25. Acute Myeloid Leukemia 18%
26. Transplantation 16%
27. Hepatitis B 15%
28. Hematopoietic Stem Cells 14%
29. Population 13%
30. Tissue Donors 13%
31. Aplastic Anaemia 13%
32. B-Cell Lymphoma 12%
33. Salvage Therapy 12%
34. Oxaliplatin 12%
35. Multivariate Analysis 12%
36. T-Cell Lymphoma 12%
37. Lymphocyte Count 11%
38. Veterans Hospitals 11%
39. Confidence Intervals 11%
40. Infections 11%
41. Myelodysplastic Syndromes 11%
42. Unrelated Donors 10%
43. Hemophagocytic Lymphohistiocytosis 10%
44. Precursor Cell Lymphoblastic Leukemia-Lymphoma 10%
45. Serum 10%
46. Cyclophosphamide 10%
47. Gene Rearrangement 10%
48. Carcinoembryonic Antigen 10%
49. Recurrence 10%
50. Breast Neoplasms 9%